Shantha Biotechnics awarded large vaccine contracts by United Nations agency
Shantha awarded 2010-2012 contracts for pentavalent vaccine SHAN5™ (DTP, HiB, Hep.B)
Sanofi Pasteur, through its existing and new contracts, now provides a full range of vaccines used within the Expanded Program on Immunization (EPI) of the World Health Organization (WHO).
Commenting on the contracts, Wayne Pisano, President and Chief Executive Officer of Sanofi Pasteur, said: “These awarded contracts underline Shantha Biotechnics’ high expertise and the quality of their state-of-the-art manufacturing facilities. While Shantha Biotechnics is joining the sanofi-aventis Group, those contracts perfectly illustrate our ambition to provide the best vaccines at affordable prices to many people around the world.”
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.